Landscapes / Companies
Autolus Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 4 in all
Trials
6 active
9 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Gene therapy substances |
Approved | Aug 2028Phase 2 trial completes | |||
| How it works | A gene therapy | ||||
| Next date | Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- AUTO3, AUTO3 (CD19/22 CAR T cells, AUTO4
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021